Biomedical Technology

GOLDEN BIOTECH LIMITED

šŸš« No Website Found šŸ¢ HKSTP Source
52 Potential

Decision Maker

Ms. Yang Li
goldenbiotechhk@gmail.com
39431100
N/A
Raw Description
Golden Biotech is a Hong Kong biotech focused on RNA-based therapeutics of cancers with high mortality such as liver cancer. The company is founded by expert with long term interest in RNA technology and cancer and teamed up with experienced professionals in finance and oncology. Our mission is to develop innovative and efficacious therapeutics to treat diseases of unmet needs such as liver cancer and fibrosis. || Product | 1. Small molecule modulators of microRNAs with anti-cancer activity. | 2. Small molecule modulators of microRNAs with anti-fibrotic activity. | 3. Technology platform for screening RNA modulators.

Strategic Analysis

Executive Brief

Golden Biotech Limited is a Hong Kong-based biotechnology firm specializing in the development of RNA-based therapeutics for high-mortality diseases, specifically liver cancer and fibrosis. Their core technical advantage lies in a proprietary screening platform designed to identify small molecule modulators of microRNAs (miRNAs), aiming to address significant unmet medical needs in oncology and chronic tissue repair.

Strategic Fit & Lead Score

Lead Score: 52 (40-59: General Research / Engineering)

Why this Score? While Golden Biotech is primarily a drug discovery firm, their Screening Technology Platform is the critical entry point for 6C. High-throughput screening (HTS) of RNA modulators requires extremely sensitive, stable, and bio-compatible sensors. 6Cā€™s Boron-Doped Diamond (BDD) electrodes offer the widest electrochemical window and lowest capacitive background noise of any material, making them superior to gold or carbon for detecting low-concentration miRNA targets and drug-target interactions without electrode fouling.

6C Solutions Proposal

Application Area 6C Solution Technical Value Prop
RNA Screening Platform BDD-coated Electrochemical Sensors Unmatched Sensitivity: BDD electrodes allow for the detection of biomolecules at trace levels with zero surface fouling, enabling reusable, high-precision screening arrays.
High-Throughput Microfluidics Diamond-on-Silicon Microchannels Biocompatibility & Flow: Diamond's extreme smoothness (Ra < 1nm) and chemical inertness prevent protein adsorption and "clogging" in microfluidic drug-screening chips.
Bio-Optical Spectroscopy PCD Optical Windows Broadband Transparency: If the platform uses UV or IR spectroscopy to verify small molecule binding, diamond provides the highest transmission with zero fluorescence interference.
R&D Analytical Tools Custom MPCVD Reactor (Benchtop) In-house IP: Allows Golden Biotech to develop proprietary, diamond-enhanced biosensors or "Lab-on-a-Chip" devices for internal screening workflows.

Engagement Hooks

  • Technical Question: "Does your current RNA screening platform face sensitivity limitations or electrode degradation when testing small molecule modulators in complex biological buffers? We have seen BDD electrodes extend sensor life by 10x while reducing signal-to-noise ratios compared to traditional carbon paste or gold electrodes."
  • Value Statement: "6C can upgrade your screening throughput and sensitivity by integrating Boron-Doped Diamond (BDD) sensing elements into your platform, ensuring your miRNA modulators are identified with the highest possible analytical precision."